Inventor · disambiguated record
Kwai Ming Cheung
Also filed as: CHEUNG KWAI MING · CHEUNG KWAI MING JACK · CHEUNG KWAI-MING J
22 granted patents·6 pending applications·126 citations·filing 2004–2024
95Inventor score
Files withCANCER RESEARCH TECH LTD12VERNALIS R&D LTD4ASTEX THERAPEUTICS LTD3CANCER REC TECH LTD2DRYSDALE MARTIN JAMES2
Top patents by PatentIndex Score
28 records- 0193US11897877B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2021·Granted Feb 13, 2024·2 cites·17 claims
- 0293US8367658B2Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their useCANCER REC TECH LTD·Filed 2011·Granted Feb 5, 2013·16 cites·19 claims
- 0393US8058045B2Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their useCOLLINS IAN·Filed 2008·Granted Nov 15, 2011·22 cites·20 claims
- 0492US9409907B2Inhibitor compoundsCANCER RES TECH LTD·Filed 2013·Granted Aug 9, 2016·14 cites·2 claims
- 0591US9890157B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Feb 13, 2018·10 cites·15 claims
- 0691US9834552B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Dec 5, 2017·8 cites·8 claims
- 0788US11046688B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2019·Granted Jun 29, 2021·2 cites·19 claims
- 0886US11512095B2BCL6 inhibitorsCANCER RESEARCH TECH LTD·Filed 2019·Granted Nov 29, 2022·7 cites·20 claims
- 0986US10479788B2Compounds that inhibit MPS1 kinaseCANCER RESEARCH TECH LTD·Filed 2018·Granted Nov 19, 2019·4 cites·19 claims
- 1086US8507480B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2010·Granted Aug 13, 2013·8 cites·30 claims
- 1184US8450310B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2012·Granted May 28, 2013·6 cites·29 claims
- 1282US10413550B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2017·Granted Sep 17, 2019·2 cites·28 claims
- 1380US11161839B22-quinolone derived inhibitors of BCL6CANCER RESEARCH TECH LTD·Filed 2018·Granted Nov 2, 2021·4 cites·19 claims
- 1480US9718793B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2013·Granted Aug 1, 2017·3 cites·29 claims
- 1580US9334286B2Pharmacologically active compoundsCANCER REC TECH LTD·Filed 2013·Granted May 10, 2016·4 cites·17 claims
- 1677US7705027B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Apr 27, 2010·7 cites·34 claims
- 1776US11234987B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2019·Granted Feb 1, 2022·0 cites·29 claims
- 1872US12110286B2Benzimidazolone derived inhibitors of BCL6CANCER RESEARCH TECH LTD·Filed 2018·Granted Oct 8, 2024·2 cites·15 claims
- 1971US9895364B2Pharmacologically active compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Feb 20, 2018·1 cites·15 claims
- 2071US2024417388A1Benzimidazolone derived inhibitors of bcl6CANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 2169US12486285B2BCL6 inhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Granted Dec 2, 2025·0 cites·22 claims
- 2268US7728016B2Substituted 5-membered ring compounds and their useVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Jun 1, 2010·4 cites·6 claims
- 2354US10188642B2Pharmacologically active compoundsCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 29, 2019·0 cites·15 claims
- 2447US2010093748A1Substituted piperidines having protein kinase inhibiting activityASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2546US2010120798A1Substituted piperidines containing a heteroarylamide or heteroarylphenyl moietyASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2646US2009054421A1Pyrimidothiophene Compounds Having HSP90 Inhibitory ActivityVERNALIS R&D LTD·Filed 2006·Application pending·0 cites
- 2745US2009124610A1Pharmaceutical compoundsSAXTY GORDON·Filed 2007·Application pending·0 cites
- 2845US2010016340A1Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →